ARCHIVES

Firm Buys Rights To NKT Cells From Beth Israel Deaconess.

This article is from The Cancer Letter archive.

Vol. 26 No. 30 | July 28, 2000

Download PDF Visit The Full Archive

Related Articles

DCPC Board Objects To Cutting Grants Each Award Year

February 17, 1989

NIH RPG Success Rate to Fall Further

June 7, 2013

Cancer Advocacy: Deal Returns $3M to Office of Women’s Health, Spends $3.5M On Workshops

August 1, 1997

In Brief: James Wallace Named CALGB Executive Officer; Gritz Receives First Joseph Cullen Award

September 11, 1992

Tests Find No Conclusive Evidence On Two Chemicals

September 21, 1979

FDA Issues MedWatch Warning, Begins Safety Review Of Prostate Cancer Drugs

May 7, 2010